JP2005506970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506970A5 JP2005506970A5 JP2003517050A JP2003517050A JP2005506970A5 JP 2005506970 A5 JP2005506970 A5 JP 2005506970A5 JP 2003517050 A JP2003517050 A JP 2003517050A JP 2003517050 A JP2003517050 A JP 2003517050A JP 2005506970 A5 JP2005506970 A5 JP 2005506970A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- substituted
- membered
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 26
- 150000002431 hydrogen Chemical class 0.000 claims description 26
- -1 hydroxy, carbamoyl Chemical group 0.000 claims description 21
- 125000000623 heterocyclic group Chemical group 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims description 12
- 150000004677 hydrates Chemical class 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 239000012453 solvate Substances 0.000 claims description 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 4
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 4
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical group OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 claims description 4
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000738 acetamido group Chemical class [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 230000001548 androgenic effect Effects 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000003386 piperidinyl group Chemical class 0.000 claims description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 230000004520 agglutination Effects 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010002388 Angina unstable Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010051055 Deep vein thrombosis Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 108010074860 Factor Xa Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 208000010378 Pulmonary Embolism Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000001435 Thromboembolism Diseases 0.000 claims 1
- 208000032109 Transient ischaemic attack Diseases 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 206010047249 Venous thrombosis Diseases 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000007796 conventional method Methods 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 238000001212 derivatisation Methods 0.000 claims 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 208000015891 sexual disease Diseases 0.000 claims 1
- 201000010875 transient cerebral ischemia Diseases 0.000 claims 1
- 0 CC(*)(C(C1=C2)=CC=CC2(C)NC(c2ccc(*)[s]2)=O)N(*B*)C1(*)I Chemical compound CC(*)(C(C1=C2)=CC=CC2(C)NC(c2ccc(*)[s]2)=O)N(*B*)C1(*)I 0.000 description 9
- 230000023555 blood coagulation Effects 0.000 description 1
- 125000000904 isoindolyl group Chemical class C=1(NC=C2C=CC=CC12)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10137163A DE10137163A1 (de) | 2001-07-30 | 2001-07-30 | Substituierte Isoindole und ihre Verwendung |
| PCT/EP2002/007957 WO2003011858A1 (de) | 2001-07-30 | 2002-07-17 | Substituierte isoindole und ihre verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506970A JP2005506970A (ja) | 2005-03-10 |
| JP2005506970A5 true JP2005506970A5 (enExample) | 2006-01-12 |
Family
ID=7693643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517050A Pending JP2005506970A (ja) | 2001-07-30 | 2002-07-17 | 置換イソインドール類およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7189738B2 (enExample) |
| EP (1) | EP1414817B1 (enExample) |
| JP (1) | JP2005506970A (enExample) |
| CA (1) | CA2455772A1 (enExample) |
| DE (2) | DE10137163A1 (enExample) |
| ES (1) | ES2240775T3 (enExample) |
| WO (1) | WO2003011858A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10134482A1 (de) * | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte Isoindole und ihre Verwendung |
| US7361672B2 (en) * | 2004-12-23 | 2008-04-22 | Hoffmann-La Roche Inc. | Heteroarylacetamide inhibitors of factor Xa |
| BRPI0618523A2 (pt) * | 2005-11-11 | 2011-09-06 | Hoffmann La Roche | compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos |
| TW200806625A (en) * | 2006-05-26 | 2008-02-01 | Astrazeneca Ab | Therapeutic compounds |
| DE102006025317A1 (de) * | 2006-05-31 | 2007-12-06 | Bayer Healthcare Aktiengesellschaft | Isoindolin-1-on-,Isoindolin-3-on und Isoindolin-1,3-dion-Derivate und ihre Verwendung |
| DE102006025318A1 (de) * | 2006-05-31 | 2007-12-06 | Bayer Healthcare Ag | Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung |
| HUP0600810A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
| TWI664165B (zh) | 2014-04-23 | 2019-07-01 | 日商武田藥品工業股份有限公司 | 含氮雜環化合物 |
| CN105061404B (zh) * | 2015-07-21 | 2017-07-11 | 广东炜林纳新材料科技股份有限公司 | 一种亚酰胺类聚丙烯β晶型成核剂及其制备方法 |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| CA3106239A1 (en) | 2018-07-27 | 2020-01-30 | Biotheryx, Inc. | Bifunctional compounds as cdk modulators |
| WO2021222150A2 (en) | 2020-04-28 | 2021-11-04 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8270898A (en) * | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
| GB9715894D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic derivatives |
| US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| DE69934093T2 (de) | 1998-01-27 | 2007-06-21 | Aventis Pharmaceuticals Inc. | SUBSTITUIERTE OXOAZAHETEROCYCLYL FAKTOR Xa HEMMER |
| US6534651B2 (en) * | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
| WO2002034711A1 (en) | 2000-10-20 | 2002-05-02 | Biocryst Pharmaceuticals, Inc. | Biaryl compounds as serine protease inhibitors |
| US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
-
2001
- 2001-07-30 DE DE10137163A patent/DE10137163A1/de not_active Withdrawn
-
2002
- 2002-07-17 US US10/485,412 patent/US7189738B2/en not_active Expired - Fee Related
- 2002-07-17 ES ES02751145T patent/ES2240775T3/es not_active Expired - Lifetime
- 2002-07-17 EP EP02751145A patent/EP1414817B1/de not_active Expired - Lifetime
- 2002-07-17 CA CA002455772A patent/CA2455772A1/en not_active Abandoned
- 2002-07-17 WO PCT/EP2002/007957 patent/WO2003011858A1/de not_active Ceased
- 2002-07-17 DE DE50202730T patent/DE50202730D1/de not_active Expired - Fee Related
- 2002-07-17 JP JP2003517050A patent/JP2005506970A/ja active Pending
-
2007
- 2007-03-12 US US11/717,414 patent/US7482472B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5614520A (en) | 2-arylthiazole derivatives and pharmaceutical composition thereof | |
| JP4792025B2 (ja) | ５−ヒドロキシインドール−３−カルボン酸エステル類誘導体およびその用途 | |
| KR880000263B1 (ko) | 디히드로피리딘 유도체의 제조방법 | |
| DE60130771D1 (de) | Substituierte heterocyclische amide | |
| YU77101A (sh) | Inhibitori renina | |
| DK1136474T3 (da) | 1-Acetyl-5-brom-4,6-dimethylindolin | |
| JP2007507551A5 (enExample) | ||
| NO20045497L (no) | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater | |
| FR2562892A1 (fr) | Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes | |
| DE50304030D1 (de) | Verfahren zur Herstellung von 5-Nitrobenzofuranen | |
| RU2008119465A (ru) | Производные циклопропилуксусной кислоты и их применение | |
| JP2004520438A5 (enExample) | ||
| HUP0100489A2 (hu) | Új piperidin-4-szulfonamid-vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények | |
| HUP0204001A2 (hu) | Helyettesített amino-metil-fenil-ciklohexán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| US4483861A (en) | Antihypertensive sulfur-containing compounds | |
| KR102076820B1 (ko) | 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체 | |
| JP2003012667A (ja) | キノリンカルボキサミド骨格を有する抗菌剤 | |
| JP2002538148A (ja) | 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬 | |
| RU2004126861A (ru) | Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в) | |
| WO2003016313A1 (en) | New compounds for treating impotence | |
| JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト | |
| JP2005515169A5 (enExample) | ||
| Hilgeroth et al. | Cage Dimeric N‐Acyl‐and N‐Acyloxy‐4‐aryl‐1, 4‐dihydropyridines as First Representatives of a Novel Class of HIV‐1 Protease Inhibitors | |
| CN101362722B (zh) | N-取代苯基-2-(1-芳基-1h-咪唑-2-巯基)乙酰胺类衍生物及其制备方法与应用 | |
| CA1052788A (fr) | Procede d'obtention de nouveaux acetamides n-substitues et les composes ainsi obtenus |